2020
In type 2 diabetes, some glucose-lowering drugs reduce HbA1c more than others; drugs do not differ for mortality.
Annals of internal medicine
PubMed • Publisher's siteResearch at a glance
Top areas of exploration
- Hypoglycemic Agents , 14 publications
- Blood Glucose , 11 publications
- Diabetes Mellitus, Type 2 , 10 publications
- Insulin , 7 publications
Research activity
My publications
Filter publications
37 publications
2020
Symptomatic Pituitary Metastasis as Initial Manifestation of Renal Cell Carcinoma: Case Report and Review of Literature.
Case reports in endocrinology
PubMed • Publisher's site2016
In type 2 diabetes treated with high-dose insulin, liraglutide reduced HBA1c.
Annals of internal medicine
PubMed • Publisher's site2015
ACP Journal Club. Review: In patients with type 2 diabetes who fast, sitagliptin reduces hypoglycemia more than sulfonylurea.
Annals of internal medicine
PubMed • Publisher's site2014
ACP Journal Club. Review: sodium-glucose cotransporter 2 inhibitors reduce HbA1c and weight but increase infections.
Annals of internal medicine
PubMed • Publisher's site